Diuretics: Basic, Pharmacological, and Clinical Aspects

in conscious rats..- Modification in renal handling of phosphate induced by Hydrochlorothiazide (HCTZ) and Amiloride (A)..- IV. Pharmacokinetics..- Influence of renal failure on the pharmacokinetics of Cicletanine..- Pharmacokinetics and -dynamics of Piretanide in chronic renal failure..- Changes in furosemide pharmacokinetics induced by dehydration..- Pharmacokinetics of Torasemide in man..- Furosemide blunts Hydrochlorothiazide (HCT) effect..- Influence of renal insufficiency on the pharmacokinetics and the renal effects of Cicletanine..- A comparison between Torasemide and Furosemide effects after application upon one kidney or after I.V. injection in the rat..- V. Endogenous Natriuretic Factors..- Receptor binding sites of Atrial Natriuretic Factor in bovine brain microvessels..- Intrarenal localization and photoaffinity labeling of receptors for ?-rat Atrial Natriuretic Polypeptide..- Atrial Natriuretic Peptide raises hematocrit in conscious nephrectomized rats..- Tubular effects of atrial extract and of Atriopeptin III in conscious rats..- Atrial Natriuretic Peptides and renin secretion..- Salt loading in spontaneously hypertensive rats further elevates blood pressure despite enhanced release of Atrial Natriuretic Peptides and exaggerated natriuresis..- Plasma cardionatrin and volume and the renin angiotensin aldosterone system in normotensive and hypertensive pregnancy..- Atrial Natriuretic Peptide as an indicator of cardiac and volume state..- Atrial Natriuretic Peptides (ANP) in rats with chronic renal failure..- Plasma levels of human Atrial Natriuretic Peptide in chronic uremic patients..- Atrial Natriuretic Peptide (ANP) and renal function: effect of posture and dietary sodium..- Involvement of Na + transport and Natruiretic hormones in the antihypertensive mechanism of Canrenone..- Inhibition of the erythrocyte Na +, K + - Pump by mammalian lignans: a possible link with endogenous digitalis..- Effects of human alpha Natriuretic Atrial Peptide on aldosterone secretion in vitro..- Interaction of platelet-activating factor with natriuresis and diuresis induced by the synthetic Atrial Natriurectic Factor (ser 99-Tyr 126) in anaesthetized dog..- Circulating Natriuretic Factor in the pathogenesis of genetic hypertension of renal origin..- Lack of correlation between plasma Ouabain-like Factor and urinary sodium excretion in essential hypertensive patients..- Atrial Natriuretic Peptide during water immersion in healthy volunteers..- VI. Aquaretics..- Symposium on aquaretics: introduction..- Some aquaretic agents other than vasopressin analogs..- Vasopressin antagonists: model aquaretic agents..- The anti-antidiuretic effect of a stable prostaglandin-E2 analog in conscious sheep and man..- Vasopression in patients with liver and cardiac disease..- Reversal of hyponatremia in experimental Schwartz-Bartter Syndrome with a vasopressin antagonist (SK&F101926)..- The vasopressin antagonist SK&F101926 is a selective aquaretic agent in dogs..- VII. Diuretics and Hypertension..- The antihypertensive mechanism of diuretics..- Metabolic effects of long-term diuretic treatment..- Anthihypertensive diuretics - old and new..- The physiology of natriuretic mechanisms in the kidney..- Intracellular electrolytes in essential hypertension during treatment with Torasemide..- The isolated perfused rat kidney as a model for the study of diuretics in hypertension..- Antihypertensive mechanisms of Muzolimine..- Indapamide: antihypertensive activity and renal effects..- In vitro effects of Furosemide on rabbit blood vessels..- Comparison of Torasemide and Indapamide in the treatment of essential hypertension..- Modifications in cardiovascular Norepinephrine responsiveness by diuretic treatment in mild renal parenchymal disease..- Muzolimine vs Captopril in Low and Mild Hypertension..- The hypotensive action of Indapamide..- Etozolin induced urine excretion of water and solutes in patients with hypertension..- Calcium metabolism in essential hypertensive patients treated with Etozolin..- Improvement in exercise-induced diastolic blood pressure changes by diuretic treatment..- Antihypertensive activity and tolerability of Thiobutizide alone or in fixed combination with potassium Canreonate in essential hypertension..- K-rich/Na-poor salt reduces blood pressure in hospitalized patients..- Combination of Nifedipine and Chlorthalidone in the treatment of hypertension..- Cardiovascular reflex and systemic hemodynamic relationship in patients with essential hypertension under chronic treatment with Indapamide..- Comparison of long term metabolic effects of Muzolimine and Chlorthalidone in patients with arterial hypertension..- Etozolin in hypertension with renal failure..- Efficacy and tolerability of Muzolimine in the long-term treatment of essential hypertension..- Muzolimine in the treatment of arterial hypertension in the elderly..- Long-term therapy with Muzolimine in patients with mild to moderate essential hypertension..- Hemodynamic changes in patients with essential hypertension after therapy with Muzolimine..- Relaxing action of Muzolimine on guinea-pig isolated aorta..- VIII. Diuretics and Cardiac Disease.- The cardiovascular effects of diuretics..- Aspects of the mechanism of action of diuretics in heart failure..- Treatment of chronic nonhydropic congestive heart failure: effect of Hydrochlorothiazide and Triamteren on cardiac performance..- Comparison of the efficacy and safety of 5mg/10mg Torasemide (TO) in patients with chronic heart failure..- Influence on water and solutes excretion determined by different adminstrations of Muzolimine and Furosemide in patients with congestive heart failure..- Evidence of improvement in myocardial contractility after acute oral Muzolimine administration..- Intraindividual comparison of effects of Piretanide, Bumetanide and Furosemide in congestive heart failure..- IX. Diuretics and Renal Disease..- Prevention of acute renal failure (ARF) by diuretics and hydration..- Comparison of dose-related efficacy of Torasemide and Furosemide in patients with advanced renal failure..- Pharmacodynamics and kinetics of Torasemide and its metabolites in chronic renal failure after i.v. Administration of 20mg Torasemide..- Muzolimine in the treatment of acute tubular necrosis following renal transplantation..- Torasemide in chronic renal failure..- Muzolimine vs Furosemide in chronic renal failure: short term effect in double-blind study..- Effects of Etozolin in uremic patients on dialysis with residual renal function..- Can high-dose diuretic therapy reduce the frequency of hemodialytic treatment?.- Use of high dose Muzolimine in acute fluid retention in patients undergoing continuous ambulatory peritoneal dialysis (CAPD)..- Double blind cross-over comparison of Muzolimine and placebo in patients on maintenance hemodialysis..- Effects of the loop-diuretic Muzolimine in rats with HgCl2 -induced acute renal failure (ARF)..- Effects of Muzolimine on experimental acute renal failure (ARF)..- Enhanced recovery of acute renal failure with Dopamine + Muzolimine..- The use of Muzolimine in nephrotic syndrome: diuretic effect and tubular functions..- Favourable effects of Muzolimine on urea plasma levels in chronic renal failure..- Furosemide as an agent enhancing peritoneal dialysis efficiency..- Furosemide and peritoneal transport of uric acid - experimental studies..- X. Diuretics in Cirrhosis..- Comparison of pharmacodynamics and pharmacokinetics of Torasemide and Furosemide in patients with ascites due to cirrhosis of the liver..- Comparative evaluation of Muzolimine and Furosemide in healthy subjects and in liver cirrhosis..- Restoration of response to diuretics with plasma expanders and Aminophylline in ascitic cirrhosis of liver..- Behavior of red blood cell potassium and of other hydro-electrolyte parameters during spironolactone treatment in patients with non compensated liver cirrhosis..- Muzolimine as treatment of ascites from hepatic cirrhosis..- XI. Diuretics and Stone Formation..- Extrarenal effects of Hydrochlorothiazide in hypercalciuric stone formers..- Causes of failure in Thiazide diuretic therapy of hypercalciuric nephrolithiasis..- Comparison of two different associations of diuretics in reducing hypercalciuria in recurrent calcium stone formers..- Medical treatment of idiopathic calcium nephrolithiasis: Thiazide (T) vs stone clinic effect..- Effect of Thiazide diuretics on hypercalciuria induced by active vitamin D metabolites..- XII. Side Effects of Diuretic Therapy..- Captopril protects against metabolic effects of chronic Hydrochlorothiazide therapy..- Gynecomastia and mastodynia after spironolactone and potassium canrenoate..- Side effects from diuretics in hospitalized patients..- Diuretic-associated hypokalemia: a prevalent and expensive disease?.- Effects of Muzolimine on free-water excretion in edematous and hyponatremic patients..- Irreversible hyponatremia due to incongruous spironolactone treatment..- The diuretic effects of lithium salts. Absence of side effects..- Renal failure due to diuretics..- The effects of Spironolactone and Amiloride on plasma electrolytes in Thiazide treated subjects..- Hemorheological effects of diuretics..- Diuretic effect and electrolyte changes caused by oral PEG 200 in rat..- XIII. Effects of Diuretics on Water and Electrolyte Excretion..- Changes in kinetics of electrolyte excretions induced by adding Triamterene to Thiazide..- Beneficial effects of Ibopamine in idiopathic edema..- Kaliuresis induced by various diuretics..- Natriuretic potency of various diuretics..- Short term effects of Muzolimine on electrolytes and acid-base balance..- Effects of Torasemide's metabolites on water and electrolyte excretion in the rat..- Role of central gabaergic system on rat diuresis..- XIV. Diuretics in Renal Investigation..- Use of diuretics to investigate renal function..- The significance of the Macula Densa mechanism for renin release..- Furosemide i.v. test to check distal acidification. Normal values in adults..- Tubular function in Bartter's syndrome and changes induced by chronic converting enzyme blockade..- Type II pseudohypoaldosteronism. Differential effects of loop diuretics and Hydrochlorothiazide..- Clinical evaluation of proximal tubule Na/fluid reabsorption: lithium clearance vs "volume or chloride factors" during maximal water diuresis and Furosemide administration..- Henle's loop (HL) reabsorption measured by Furosemide (F)..- XV. Effects of Diuretics on Renal Function..- Effects of the new uricosuric diuretic Bay r 4420 on rat kidney function..- Characterization of the renal and hormonal effects of three novel antimineralocorticoids in vitro and in vivo..- Renal effects of Etozolin in Man..- Effects of Enalapril on water and salt balance and renal hemodynamics..- XVI. Diuretics and Prostaglandins..- Effect of Indomethacin on the saluretic activity of Bumetanide..- Role of renal prostaglandins in mediating the activity of Muzolimine in man..- Cicletanine -an antihypertensive drug with a powerful natriuretic effect; role of renal prostaglandins..- Effects of Muzolimine on renal prostaglandin biosynthesis in healthy subjects..- Effect of Muzolimine on Prostaglandin E2 synthesis and catabolism in rat kidney..